Klotho Sensitivity of the Neuronal Excitatory Amino Acid Transporters EAAT3 and EAAT4
Authors:
Open Access
- 29 July 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (7) , e70988
Abstract
Klotho, a transmembrane protein, which can be cleaved off as β-glucuronidase and hormone, is released in both, kidney and choroid plexus and encountered in blood and cerebrospinal fluid. Klotho deficiency leads to early appearance of age-related disorders and premature death. Klotho may modify transport by inhibiting 1,25(OH)2D3 formation or by directly affecting channel and carrier proteins. The present study explored whether Klotho influences the activity of the Na+-coupled excitatory amino acid transporters EAAT3 and EAAT4, which are expressed in kidney (EAAT3), intestine (EAAT3) and brain (EAAT3 and EAAT4). To this end, cRNA encoding EAAT3 or EAAT4 was injected into Xenopus oocytes with and without additional injection of cRNA encoding Klotho. EAAT expressing Xenopus oocytes were further treated with recombinant human β-Klotho protein with or without β-glucuronidase inhibitor D-saccharic acid 1,4-lactone monohydrate (DSAL). Electrogenic excitatory amino acid transport was determined as L-glutamate-induced current (Iglu) in two electrode voltage clamp experiments. EAAT3 and EAAT4 protein abundance in the Xenopus oocyte cell membrane was visualized by confocal microscopy and quantified utilizing chemiluminescence. As a result, coexpression of Klotho cRNA significantly increased Iglu in both, EAAT3 or EAAT4-expressing Xenopus oocytes. Klotho cRNA coexpression significantly increased the maximal current and cell membrane protein abundance of both EAAT3 and EAAT4. The effect of Klotho coexpression on EAAT3 and EAAT4 activity was mimicked by treating EAAT3 or EAAT4-expressing Xenopus oocytes with recombinant human β-Klotho protein. The effects of Klotho coexpression and of treatment with recombinant human β-Klotho protein were both abrogated in the presence of DSAL (10 µM). In conclusion, Klotho is a novel, powerful regulator of the excitatory amino acid transporters EAAT3 and EAAT4.Keywords
This publication has 76 references indexed in Scilit:
- Hippocampal gene expression dysregulation of Klotho, nuclear factor kappa B and tumor necrosis factor in temporal lobe epilepsy patientsJournal of Neuroinflammation, 2013
- Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic miceJournal of Clinical Investigation, 2013
- Action control is mediated by prefrontal BDNF and glucocorticoid receptor bindingProceedings of the National Academy of Sciences, 2012
- RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patientsJournal of Affective Disorders, 2012
- Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubuleThe FASEB Journal, 2010
- Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophreniaSchizophrenia Research, 2010
- Regulation of Renal Outer Medullary Potassium Channel and Renal K+ Excretion by KlothoMolecular Pharmacology, 2009
- Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1α-hydroxylaseKidney International, 2009
- Glutamate forward and reverse transport: From molecular mechanism to transporter‐mediated release after ischemiaIUBMB Life, 2008
- Preliminary Evidence of Riluzole Efficacy in Antidepressant-Treated Patients with Residual Depressive SymptomsBiological Psychiatry, 2007